1 | 76932 | Induction of remission in hepatocellular carcinoma with doxorubicin. | Lancet | 1978 May 13 |
1 |
2 | 77725 | Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine. | Cancer Treat Rep | 1978 Apr |
1 |
3 | 94197 | [Therapy of non-Hodgkin lymphomas]. | Z Gesamte Inn Med | 1979 Jul 1 |
1 |
4 | 132786 | [Adriamycin, cyclophosphamide, and 5-fluorouracil in the treatment of metastasizing breast cancer (author's transl)]. | Z Krebsforsch Klin Onkol Cancer Res Clin Oncol | 1976 Jun 15 |
1 |
5 | 206337 | CCNU-adriamycin therapy in bronchogenic carcinoma. | Cancer | 1978 May |
1 |
6 | 364284 | Improvement in complete response rate, duration of response and survival with adriamycin combination chemotherapy for non-Hodgkin lymphoma: a prognostic factor comparison of two regimens. | Med Pediatr Oncol | 1978 |
1 |
7 | 373915 | Clinical, toxicological, and pharmacological studies of combination chemotherapy of adenocarcinoma with adriamycin and Baker's antifolate. | Cancer Chemother Pharmacol | 1978 |
3 |
8 | 455570 | Evaluation of cardiac activity and pharmacokinetic analysis of 3H-adriamycin in patients pretreated with beta-methyldigoxin. | Cancer Chemother Pharmacol | 1979 |
1 |
9 | 476691 | Quantitative models for growth inhibition of human leukemia cells by antitumor anthracycline derivatives. | Cancer Res | 1979 Sep |
1 |
10 | 526938 | Alterations of lactate dehydrogenase isoenzymes with subacute adriamycin toxicity. | Cancer Treat Rep | 1979 Nov-Dec |
2 |
11 | 528271 | Effects of adriamycin and X-rays on euoxic and hypoxic EMT-6 cells in vitro. | Int J Radiat Oncol Biol Phys | 1979 Aug |
1 |
12 | 528363 | Mechanism of action of the anthracycline anti-tumor antibiotics, doxorubicin, daunomycin and rubidazone: preferential inhibition of DNA polymerase alpha. | J Antibiot (Tokyo) | 1979 Oct |
1 |
13 | 535135 | Evaluation of early doxorubicin-induced cardiotoxicity by means of systolic time intervals. | Cancer Chemother Pharmacol | 1979 |
1 |
14 | 911351 | Effect of daunomycin, adriamycin and its congener AD 32 on the activity of DNase I from bovine pancreas. | Biochem Pharmacol | 1977 Oct 15 |
1 |
15 | 975096 | Effect of deoxyribonuclease on adriamycin-polynucleotide complexes. | Cancer Res | 1976 Sep |
2 |
16 | 1271407 | Cellular pharmocodynamics of several anthrocycline antibiotics. | J Med Chem | 1976 May |
1 |
17 | 1279258 | [Adjuvant chemotherapy with MVP-CAB (methotrexate, vincristine, cisplatinum, cyclophosphamide, adriamycin and bleomycin) for epithelial tumors of the upper urinary tract]. | Nihon Hinyokika Gakkai Zasshi | 1992 Oct |
1 |
18 | 1280141 | Doxorubicin inhibits differentiation and enhances expression of the helix-loop-helix genes Id and mTwi in mouse osteoblastic cells. | Biochem Int | 1992 Oct |
1 |
19 | 1283520 | Adriamycin, bleomycin and vincristine chemotherapy with recombinant granulocyte-macrophage colony-stimulating factor in the treatment of AIDS-related Kaposi's sarcoma. | AIDS | 1992 Dec |
1 |
20 | 1285922 | Modification of adriamycin-induced cytotoxicity by recombinant human interferon-gamma and/or verapamil in human stomach cancer cells. | J Korean Med Sci | 1992 Sep |
2 |
21 | 1292755 | Synergistic antiproliferative effects of the combination of interleukin-1 alpha and doxorubicin against human melanoma cells. | Oncol Res | 1992 |
7 |
22 | 1296877 | [The effect of superoxide dismutase and catalase on the delayed toxicity of doxorubicin]. | Cardiologia | 1992 Oct |
5 |
23 | 1318109 | Effect of atrial natriuretic factor on renal cGMP production in rats with adriamycin-induced nephrotic syndrome. | J Am Soc Nephrol | 1992 Apr |
3 |
24 | 1324674 | Studies on the molecular pharmacology of GR63178A. A novel pentacyclic pyrolloquinone anticancer drug. | Biochem Pharmacol | 1992 Aug 4 |
1 |
25 | 1325792 | Comparative effects of protein phosphatase inhibitors (okadaic acid and calyculin A) on human leukemia HL60, HL60/ADR and K562 cells. | Biochem Biophys Res Commun | 1992 Aug 31 |
3 |
26 | 1326212 | Tumor debulking followed by immediate combination chemotherapy in advanced ovarian carcinoma. Phase II. | Acta Obstet Gynecol Scand | 1992 Jul |
1 |
27 | 1326307 | Comparative studies on the effects of doxorubicin and differentiation inducing agents on B16 melanoma cells. | Eur J Cancer | 1992 |
1 |
28 | 1330347 | Expression of topoisomerase II, catalase, metallothionein and thymidylate-synthase in human squamous cell lung carcinomas and their correlation with doxorubicin resistance and with patients' smoking habits. | Carcinogenesis | 1992 Nov |
2 |
29 | 1334113 | Pharmacologic validation of human tumor clonogenic assays based on pleiotropic drug resistance: implications for individualized chemotherapy and new drug screening programs. | Int J Cell Cloning | 1992 Nov |
1 |
30 | 1338282 | Elevated expression of thymidylate synthase in doxorubicin resistant human non small cell lung carcinomas. | Anticancer Res | 1992 Nov-Dec |
3 |
31 | 1348623 | P-glycoprotein overexpression cannot explain the complete doxorubicin-resistance phenotype in rat glioblastoma cell lines. | Br J Cancer | 1992 Apr |
1 |
32 | 1348862 | Genetic transfer of non-P-glycoprotein-mediated multidrug resistance (MDR) in somatic cell fusion: dissection of a compound MDR phenotype. | Proc Natl Acad Sci U S A | 1992 Apr 15 |
1 |
33 | 1349283 | Overexpression of the multidrug resistance gene product in adult rat hepatocytes during primary culture. | Eur J Biochem | 1992 Apr 15 |
2 |
34 | 1349796 | Further characterization of two distinct adriamycin-resistant sublines from LoVo human colon carcinoma cells. | Anticancer Res | 1992 Mar-Apr |
1 |
35 | 1349797 | A single 24h contact time with adriamycin provokes the emergence of resistant cells expressing the Gp 170 protein. | Anticancer Res | 1992 Mar-Apr |
1 |
36 | 1352455 | Mechanisms of multidrug resistance in cancer treatment. | Acta Oncol | 1992 |
1 |
37 | 1352990 | Modulation of P-glycoprotein phosphorylation and drug transport by sodium butyrate. | Biochemistry | 1992 Jul 21 |
1 |
38 | 1353119 | Establishment and characterization of doxorubicin-resistant human bladder cancer cell line, KK47/ADM. | J Urol | 1992 Aug |
5 |
39 | 1353189 | Modulation of multidrug-resistant multiple myeloma by cyclosporin. The Leukaemia Group of the EORTC and the HOVON. | Lancet | 1992 Aug 1 |
1 |
40 | 1353703 | Cytogenetic alterations associated with P-glycoprotein- and non-P-glycoprotein-mediated multidrug resistance in SW-1573 human lung tumor cell lines. | Cancer Res | 1992 Aug 15 |
2 |
41 | 1354408 | Establishment and characterization of an etoposide-resistant human small cell lung cancer cell line. | Acta Med Okayama | 1992 Jun |
1 |
42 | 1355336 | Overexpression of erbB-2 protein in gastric adenocarcinoma--a potential role in therapeutic response to adjuvant 5-FU-doxorubicin regimen. | Gan To Kagaku Ryoho | 1992 Jul |
2 |
43 | 1356264 | Partial purification and reconstitution of the human multidrug-resistance pump: characterization of the drug-stimulatable ATP hydrolysis. | Proc Natl Acad Sci U S A | 1992 Sep 15 |
1 |
44 | 1356339 | Overexpression of P-glycoprotein and alterations in topoisomerase II in P388 mouse leukemia cells selected in vivo for resistance to mitoxantrone. | Biochem Pharmacol | 1992 Sep 1 |
1 |
45 | 1356441 | In archaebacteria, there is a doxorubicin efflux pump similar to mammalian P-glycoprotein. | Biochim Biophys Acta | 1992 Oct 5 |
1 |
46 | 1356622 | Decreased P-glycoprotein expression in multidrug-sensitive and -resistant human myeloma cells induced by the cytokine leukoregulin. | Cancer Res | 1992 Nov 1 |
3 |
47 | 1357834 | The value of immunohistochemical detection of P-glycoprotein in breast cancer before and after induction chemotherapy. | Yonsei Med J | 1992 Jun |
1 |
48 | 1358410 | Clinical significance of erbB-2 (HER-2/neu) protein. | Cancer Invest | 1992 |
1 |
49 | 1358437 | A new functional role for P-glycoprotein: efflux pump for benzo(alpha)pyrene in human breast cancer MCF-7 cells. | Cancer Res | 1992 Dec 1 |
1 |
50 | 1358894 | Adriamycin binding assay: a valuable chemosensitivity test in human osteosarcoma. | J Cancer Res Clin Oncol | 1992 |
2 |